Incidence of Mucositis in Patients Treated With Temsirolimus-Based Regimens and Correlation to Treatment Response. (25th March 2014)

• Record Type: Journal Article
• Authors: Liu, Xiaochun; LoRusso, Patricia; Mita, Monica; Piha-Paul, Sarina; Hong, David S.; Fu, Siqing; McQuinn, Lacey; Asatiani, Ekaterine; Doyle, Lawrence A.; Chen, Helen X.; Hess, Kenneth R.; Kurzrock, Razelle; Naing, Aung
• Is Part Of: Oncologist. Volume 19:Number 4(2014)
• Page Start: 426
• Page End: 428
• Publication Date: 2014-03-25
• Subjects: Oncology -- Periodicals; Tumors -- Periodicals; Cancérologie -- Périodiques; Tumeurs -- Périodiques; Oncology; Tumors; Neoplasms; Electronic journals; Periodicals; Periodicals; 616.994
• DOI: 10.1634/theoncologist.2013-0231
• Languages: English
• ISSNs: 1083-7159

Abstract

Abstract : Mucositis may limit the therapeutic window for mammalian target of rapamycin inhibitor-based combination therapy, necessitating treatment interruptions and/or dose reductions. Optimizing treatment or prophylactic interventions for mucositis will enable patients to continue effective treatment while maintaining good quality of life.